Literature DB >> 20590393

Dietary supplementation: effects on visual performance and occurrence of AMD and cataracts.

Felix M Barker1.   

Abstract

OBJECTIVE: To evaluate results of studies that have provided information regarding the effects of dietary supplementation on visual performance, development and progression of age-related macular degeneration (AMD), and risk for cataracts. RESEARCH DESIGN AND METHODS: Studies with information about the effects of dietary supplementation were identified via PubMed searches that combined (in separate searches) the terms 'supplement' OR 'supplementation' OR 'diet' AND 'cataract' or 'macular degeneration' or 'visual' OR 'vision'. Additional references concerned with biologic effects of specific agents, measurement of visual function, and the etiology and epidemiology of cataracts and AMD were identified on the basis of PubMed conventional literature searches.
RESULTS: Studies of the effects of dietary supplementation, primarily with preparations including lutein and zeaxanthin, have demonstrated improvements in contrast sensitivity and visual performance under glare conditions that, in some studies, have been correlated with effects of treatment on macular pigment optical density. Results from both observational and prospective interventional studies generally support the conclusion that dietary supplements including these xanthophylls significantly decrease the occurrence of AMD and the development of nuclear lens opacities. However, there is variability in results regarding effects of dietary supplementation that may be related to limitations of long-term observational or interventional studies and which cannot be easily controlled or which may also be related in some studies to other important, yet unrecorded, diet- and lifestyle-related factors that are capable of influencing the risks for AMD and/or cataracts.
CONCLUSIONS: The multiple benefits of dietary supplementation support the development and use of these preparations to promote optimal visual function and decrease risk for AMD and cataracts. Increasing understanding of the optimal approach to supplementation will depend upon results from interventional studies that also carefully evaluate and analyze well-established factors for these two conditions.

Entities:  

Mesh:

Year:  2010        PMID: 20590393     DOI: 10.1185/03007995.2010.494549

Source DB:  PubMed          Journal:  Curr Med Res Opin        ISSN: 0300-7995            Impact factor:   2.580


  5 in total

1.  Zeaxanthin inhibits hypoxia-induced VEGF secretion by RPE cells through decreased protein levels of hypoxia-inducible factors-1α.

Authors:  Richard Rosen; Tommaso Vagaggini; Yueqin Chen; Dan-Ning Hu
Journal:  Biomed Res Int       Date:  2015-01-20       Impact factor: 3.411

Review 2.  The Pharmacological Effects of Lutein and Zeaxanthin on Visual Disorders and Cognition Diseases.

Authors:  Yu-Ping Jia; Lei Sun; He-Shui Yu; Li-Peng Liang; Wei Li; Hui Ding; Xin-Bo Song; Li-Juan Zhang
Journal:  Molecules       Date:  2017-04-20       Impact factor: 4.411

Review 3.  The role of lutein in eye-related disease.

Authors:  Keyvan Koushan; Raluca Rusovici; Wenhua Li; Lee R Ferguson; Kakarla V Chalam
Journal:  Nutrients       Date:  2013-05-22       Impact factor: 5.717

Review 4.  Epimacular brachytherapy for wet AMD: current perspectives.

Authors:  Ricardo P Casaroli-Marano; Socorro Alforja; Joan Giralt; Michel E Farah
Journal:  Clin Ophthalmol       Date:  2014-08-30

Review 5.  Management of Ocular Diseases Using Lutein and Zeaxanthin: What Have We Learned from Experimental Animal Studies?

Authors:  Chunyan Xue; Richard Rosen; Adrienne Jordan; Dan-Ning Hu
Journal:  J Ophthalmol       Date:  2015-11-05       Impact factor: 1.909

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.